NEXGEL, INC. Proceeds from Sale and Maturity of Marketable Securities
NEXGEL, INC. (NXGL) reported Proceeds from Sale and Maturity of Marketable Securities of $68.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2026-03-31
- NEXGEL, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2024-12-31 was $6.00K, a 98.33% decline year-over-year.
- NEXGEL, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2024-09-30 was $5.00K, a 99.12% decline year-over-year.
- NEXGEL, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2024-06-30 was $23.00K, a 99.46% decline year-over-year.
- NEXGEL, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2024-03-31 was $34.00K, a 92.99% decline year-over-year.
- NEXGEL, INC. proceeds from sale and maturity of marketable securities for fiscal 2024 was $68.00K, a 98.81% decline from fiscal 2023.
- NEXGEL, INC. proceeds from sale and maturity of marketable securities for fiscal 2023 was $5.70M, a 279.93% increase from fiscal 2022.
- NEXGEL, INC. proceeds from sale and maturity of marketable securities for fiscal 2022 was $1.50M.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2024-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $11.00K derived: sum of 2 quarters · filed 2026-03-31 | $34.00K derived: sum of 3 quarters · filed 2026-03-31 | $68.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $28.00K derived: sum of 2 quarters · filed 2024-11-13 | $62.00K 10-Q · filed 2024-11-13 | $421.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $57.00K 10-Q · filed 2024-08-19 | $416.00K derived: sum of 3 quarters · filed 2025-05-13 | $984.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-03-31 | $34.00K 10-Q · filed 2025-05-13 | $393.00K derived: sum of 2 quarters · filed 2025-05-13 | $961.00K derived: sum of 3 quarters · filed 2025-05-13 | $5.25M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $359.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $927.00K derived: sum of 2 quarters · filed 2025-03-27 | $5.21M derived: sum of 3 quarters · filed 2025-03-27 | $5.70M 10-K · filed 2025-03-27 |
| 2023-09-30 | $568.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $4.86M derived: sum of 2 quarters · filed 2024-11-13 | $5.34M 10-Q · filed 2024-11-13 | $5.84M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $4.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $4.77M 10-Q · filed 2024-08-19 | $5.27M derived: sum of 3 quarters · filed 2024-08-19 | |
| 2023-03-31 | $485.00K 10-Q · filed 2024-05-13 | $985.00K derived: sum of 2 quarters · filed 2024-05-13 | ||
| 2022-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $1.50M 10-K · filed 2024-04-10 | ||
| 2022-09-30 | $1.00M 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |